Sophos Biotech was founded by a teamof experts - with a long and consolidated experience in the pharmaceutical industry- who made their acquired professionalskills available to promote the development of scientific knowledge. Sophos Biotech aims to market highquality oncology drugs while considering very carefully their economic impact on the National Health System. One of Sophos Biotech’s guiding principles is to facilitate the access to the best therapies making them available to an increasingly large number of patients while pursuing excellence through the highest quality and safety standards. Sophos Biotech owns a portfolio of only oncological drugs and it is committed, not only to their development and distribution, but also to establish a direct dialogue with the healthcare professionals to promote a general correct use of the drugs with a specific focus on the g enerics. Furthermore, the company was founded with the precise purpose to increase awareness of the invaluable role played by the g enerics i n the treatment of serious diseases such as cancer and how - maintaining top-level efficacy and safety standards- they can help both State and patients to significantly cut their expenses.)